{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T04:23:18Z","timestamp":1741926198047,"version":"3.38.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03251-1","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T22:01:49Z","timestamp":1727215309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the effect of vitreomacular interface disorders on anti-VEGF treatment in patients with diabetic macular edema in real life: MARMASIA study group report No. 10"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5570-799X","authenticated-orcid":false,"given":"Erdin\u00e7","family":"Bozkurt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7580-5514","authenticated-orcid":false,"given":"Fatih Bilgehan","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6260-6716","authenticated-orcid":false,"given":"Ecem","family":"\u00d6nder Toku\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5426-1992","authenticated-orcid":false,"given":"Aslan","family":"Aykut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0101-1900","authenticated-orcid":false,"given":"I\u015f\u0131lay","family":"\u00d6zsoy Sayg\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6505-9714","authenticated-orcid":false,"given":"Hatice Selen","family":"Kanar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7367-2906","authenticated-orcid":false,"given":"I\u015f\u0131l","family":"Kutlut\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7130-4798","authenticated-orcid":false,"given":"Mehmet Orkun","family":"Sevik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0073-4747","authenticated-orcid":false,"given":"U\u011fur","family":"Yayla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8681-7868","authenticated-orcid":false,"given":"Erkan","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-5979","authenticated-orcid":false,"given":"Ay\u015fe","family":"Demirciler S\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-7496","authenticated-orcid":false,"given":"Tugba","family":"Aydogan Gezginaslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4998-1896","authenticated-orcid":false,"given":"Utku","family":"Limon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-6566","authenticated-orcid":false,"given":"Esra","family":"T\u00fcrkseven Kumral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8730-2495","authenticated-orcid":false,"given":"Nimet Ye\u015fim","family":"Er\u00e7al\u0131k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7299-9528","authenticated-orcid":false,"given":"\u00d6zlem","family":"Ayd\u0131n \u00d6nc\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4894-7116","authenticated-orcid":false,"given":"Ece","family":"Ba\u015faran Emengen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1940-8669","authenticated-orcid":false,"given":"Abdullah","family":"\u00d6zkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6791-2915","authenticated-orcid":false,"given":"Banu","family":"A\u00e7\u0131kal\u0131n \u00d6ncel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9940-8599","authenticated-orcid":false,"given":"Nursal Melda","family":"Yenerel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2907-2852","authenticated-orcid":false,"given":"\u00d6zlem","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7860-4603","authenticated-orcid":false,"given":"Veysel Levent","family":"Karaba\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"issue":"3","key":"3251_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R et al (2012) Meta-Analysis for eye disease (META-EYE) study group. global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35(3):556\u2013564","journal-title":"Diabetes Care"},{"key":"3251_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1155\/2015\/392983","volume":"2015","author":"D Agarwal","year":"2015","unstructured":"Agarwal D, Gelman R, Prospero Ponce C et al (2015) The vitreomacular interface in diabetic retinopathy. J Ophthalmol 2015:392\u2013983","journal-title":"J Ophthalmol"},{"issue":"24","key":"3251_CR3","doi-asserted-by":"publisher","first-page":"00182","DOI":"10.1016\/j.oret.2024.04.008","volume":"S2468\u20136530","author":"H Mehta","year":"2024","unstructured":"Mehta H, Gabrielle PH, Hashimoto Y et al (2024) One-Year anti-VEGF therapy outcomes in diabetic macular edema based on Treatment intensity: data from the fight retinal blindness! Regist Ophthalmol Retina S2468\u20136530(24):00182\u201300189. https:\/\/doi.org\/10.1016\/j.oret.2024.04.008","journal-title":"Regist Ophthalmol Retina"},{"issue":"3","key":"3251_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4103\/joco.joco_6_21","volume":"33","author":"A Inaltekin","year":"2021","unstructured":"Inaltekin A, Bozkurt E, K\u0131vrak Y (2021) Factors associated with pain level in patients receiving intravitreal injection. J Curr Ophthalmol 33(3):323\u2013329","journal-title":"J Curr Ophthalmol"},{"key":"3251_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.tjo.2013.12.001","volume":"4","author":"AL Levison","year":"2014","unstructured":"Levison AL, Kaiser PK (2014) Vitreomacular interface diseases: diagnosis and management. Taiwan J Ophthalmol 4:63\u201368","journal-title":"Taiwan J Ophthalmol"},{"issue":"8","key":"3251_CR6","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/bjophthalmol-2017-310155","volume":"101","author":"P Xie","year":"2017","unstructured":"Xie P, Zheng X, Yu Y et al (2017) Vitreomacular adhesion or vitreomacular traction may affect antivascular endothelium growth factor treatment for neovascular age-related macular degeneration. Br J Ophthalmol 101(8):1003\u20131010","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"3251_CR7","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1136\/bjophthalmol-2014-305966","volume":"99","author":"KhI Akbar","year":"2015","unstructured":"Akbar KhI, Mohamed MD, Mann SS et al (2015) Prevalence of vitreomacular interface abnormalities on spectral domain optical coherence tomography of patients undergoing macular photocoagulation for centre involving diabetic macular oedema. Br J Ophthalmol 99(8):1078\u20131081","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"3251_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.oret.2016.11.001","volume":"1","author":"MA Zapata","year":"2017","unstructured":"Zapata MA, Figueroa MS, Esteban Gonz\u00e1lez E et al (2017) SERV-VMT study group. Prevalence of vitreoretinal interface abnormalities on spectral-domain OCT in healthy participants over 45 years of age. Ophthalmol Retina 1(3):249\u2013254","journal-title":"Ophthalmol Retina"},{"issue":"13","key":"3251_CR9","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","volume":"372","author":"JA Wells","year":"2015","unstructured":"Wells JA, Glassman AR, Ayala AR et al (2015) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 372(13):1193\u20131203","journal-title":"N Engl J Med"},{"issue":"12","key":"3251_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/jcm11123266","volume":"11","author":"A Lin","year":"2022","unstructured":"Lin A, Xia H, Zhang A et al (2022) Vitreomacular interface disorders in proliferative diabetic retinopathy: an optical coherence TOMOGRAPHY STUDY. J Clin Med 11(12):32\u201366","journal-title":"J Clin Med"},{"issue":"3","key":"3251_CR11","first-page":"231","volume":"2","author":"R Duman","year":"2018","unstructured":"Duman R, \u00c7etinkaya E, Duman R (2018) Vitreomak\u00fcler Ara Y\u00fczey Hastal\u0131klar\u0131nda Klinik. Tan\u0131 ve S\u0131n\u0131fland\u0131rma Current Retian 2(3):231\u2013235","journal-title":"Tan\u0131 ve S\u0131n\u0131fland\u0131rma Current Retian"},{"key":"3251_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.4274\/tjo.galenos.2023.56249","volume":"53","author":"U Yayla","year":"2023","unstructured":"Yayla U, Sevik MO, Karaba\u015f VL et al (2023) Real-world outcomes of intravitreal anti-vascular endothelial growth factor treatment for Diabetic macular edema in T\u00fcrkiye: MARMASIA study group report No. 1. Turk J Ophthalmol 53:356\u2013368","journal-title":"Turk J Ophthalmol"},{"issue":"5","key":"3251_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/eye.2016.317","volume":"31","author":"CK Chang","year":"2017","unstructured":"Chang CK, Cheng CK, Peng CH (2017) The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF. Eye (Lond) 31(5):762\u2013770","journal-title":"Eye (Lond)"},{"issue":"2","key":"3251_CR14","doi-asserted-by":"publisher","first-page":"100019","DOI":"10.1016\/j.xops.2021.100019","volume":"1","author":"G Liew","year":"2021","unstructured":"Liew G, Nguyen H, Ho IV et al (2021) Prevalence of vitreoretinal interface disorders in an Australian population: the blue mountains eye study. Ophthalmol Sci 1(2):100019","journal-title":"Ophthalmol Sci"},{"issue":"8","key":"3251_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.oret.2020.02.013","volume":"4","author":"NB Quinn","year":"2020","unstructured":"Quinn NB, Steel DH, Chakravarthy U et al (2020) Assessment of the vitreomacular interface using high-resolution OCT in a population-based cohort study of older adults. Ophthalmol Retina 4(8):801\u2013813","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"3251_CR16","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.3390\/jcm11123266","volume":"11","author":"A Lin","year":"2022","unstructured":"Lin A, Xia H, Zhang A et al (2022) Vitreomacular interface disorders in proliferative diabetic retinopathy: an optical coherence tomography study. J Clin Med 11(12):3266","journal-title":"J Clin Med"},{"key":"3251_CR17","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/aos.14422","volume":"98","author":"MN Delyfer","year":"2020","unstructured":"Delyfer MN, Legout P, Le Goff M et al (2020) Prevalence of epiretinal membranes in the ageing population using retinal colour images and SD-OCT: the alienor study. Acta Ophthalmol 98:830\u2013838","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"3251_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/iovs.64.10.9","volume":"64","author":"ZA Jarrar","year":"2023","unstructured":"Jarrar ZA, Ansari AS, Williams KM et al (2023) Prevalence, concordance, and heritability of vitreomacular interface abnormalities in a twin study. Invest Ophthalmol Vis Sci 64(10):9","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3251_CR19","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10792-013-9884-6","volume":"34","author":"D Yoon","year":"2014","unstructured":"Yoon D, Rusu I, Barbazetto I (2014) Reduced effect of anti-vascular endothelial growth factor agents on diabetics with vitreomacular interface abnormalities. Int Ophthalmol 34(4):817\u2013823","journal-title":"Int Ophthalmol"},{"issue":"1","key":"3251_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00417-018-4173-8","volume":"257","author":"MR Romano","year":"2019","unstructured":"Romano MR, Allegrini D, Guardia CD et al (2019) Vitreous and intraretinal macular changes in diabetic macular edema with and without tractional components. Graefe\u2019s Arch Clin Exp Ophthalmol 257(1):1\u20138","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"8","key":"3251_CR21","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1167\/iovs.19-26788","volume":"60","author":"R Namba","year":"2019","unstructured":"Namba R, Kaneko H, Suzumura A et al (2019) In vitro epiretinal membrane model and antibody permeability: relationship with anti-VEGF resistance in diabetic macular edema. Investig Ophthalmol Vis Sci 60(8):2942\u20132949","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"3251_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/00006982-200002000-00004","volume":"20","author":"A Gandorfer","year":"2000","unstructured":"Gandorfer A, Messmer EM, Ulbig MW et al (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 20(2):126\u2013133","journal-title":"Retina"},{"key":"3251_CR23","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.2147\/OPTH.S146019","volume":"11","author":"AN Kulikov","year":"2017","unstructured":"Kulikov AN, Sosnovskii SV, Berezin RD et al (2017) Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study. Clin Ophthalmol 11:1995\u20132002","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"3251_CR24","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1097\/IAE.0000000000003594","volume":"42","author":"G Mylonas","year":"2022","unstructured":"Mylonas G, Najeeb BH, Goldbach F et al (2022) The impact of the vitreomacular interface on functional and anatomical outcomes in diabetic macular edema treated with three different anti-VEGF agents: post hoc analysis of the protocol T study. Retina 42(11):2066\u20132074","journal-title":"Retina"},{"key":"3251_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2023.103555","volume":"42","author":"Y Gong","year":"2023","unstructured":"Gong Y, Wang M, Li Q et al (2023) Evaluating the effect of vitreomacular interface abnormalities on anti-vascular endothelial growth factor treatment outcomes in diabetic macular edema by optical coherence tomography: a systematic review and meta-analysis. Photodiagnosis Photodyn Ther 42:103555","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"8","key":"3251_CR26","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00417-018-4009-6","volume":"256","author":"M Mikhail","year":"2018","unstructured":"Mikhail M, Stewart S, Seow F et al (2018) Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy. Graefe\u2019s Arch Clin Exp Ophthalmol 256(8):1411\u20131418","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03251-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:45:41Z","timestamp":1741880741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03251-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3251"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03251-1","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2024,9,24]]},"assertion":[{"value":"24 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"391"}}